insurance coverage for glp 1 medications of Obesity Therapies in State-Regulated Markets Why Won't Insurance Cover Weight
Description
Salcedo I, et al
Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al
Insulin and leptin levels drop precipitously, both of which have downstream effects on follicular health
The partnership with Novo Nordisk is a strong example of how GoodRx can leverage its extensive reach and scale of nearly 30 million consumers and over 1 million healthcare professionals annually to deliver meaningful savings on FDA-approved medications to people who might otherwise be priced out of therapy, Divya Iyer, senior vice president of go-to-market strategy at GoodRx told BioXconomy
